|
Novartis opens drug research center in MIT's Tech Square
 |
|
The press conference announcing Novartis' move to Tech Square. Photo by Donna Coveney. |
Swiss-based pharmaceutical giant Novartis—drawn like "a magnet" to Cambridge's confluence of brainpower, academic and medical institutions, biotech companies, and congenial political and economic policies—is creating a world-wide drug discovery center on MIT commercial property in Technology Square. "Why Cambridge?" asked Dr. Daniel Vasella, chairman and CEO of Novartis AG in a Monday news conference at the Massachusetts Institute of Technology. "Analysis shows that it is more and more difficult to attract and retain scientific talent, so we have to go where the talent is. Cambridge is a pool of . . . [read more]
Research universities boost Hub by $7B
 |
|
Universities contribute to greater Boston's fiscal health.
|
Greater Boston's eight research universities—magnets for talent and billions of dollars in investment—will play a key role in the region's economic recovery by continuing to expand knowledge and technology that creates new industries and jobs, according to a study released Tuesday, March 11.
"Engines of Economic Growth" is a detailed report on the economic and social impact in 2000 and 2002 of Boston College, Boston University, Brandeis University, Harvard University, MIT, Northeastern University, Tufts Univer-sity and the University of Massachusetts at Boston.
In 2000 alone, the study found . . . [read more]
Cambridge, MIT are magnets for biotech
The decision of pharmaceutical giant Novartis to move its research center into Technology Square in Cambridge, Mass. is confirmation of the status of this small city of 101,000 as a world magnet for biotechnology and pharmaceutical companies. The heart of the biotech/pharmaceutical area is the circle of development around MIT. Up the Charles River is Harvard University; across the river are . . . [read more]
MIT to use nanomaterials to clothe, equip Army soldiers
 |
|
Participants at the press conference announcing the selection of MIT for a $50 million nanotechnology for soldiers program. Photo by Donna Coveney.
|
The United States Army has selected MIT to create lightweight molecular materials to equip the foot soldiers of the future with uniforms and gear that can heal them, shield them and protect them against chemical and biological warfare.
MIT won the Army competition for the five-year, $50 million proposal for an Institute for Soldier Nanotechnologies (ISN). Industry will contribute . . . [read more]
MIT hosts celebration of Kendall biotech community
More than 500 leaders from local biotech companies, venture capital firms, industry groups and MIT gathered inside and outside the Whitaker College of Health Sciences and Technology (Building E25) on Aug. 22 to celebrate the Kendall Square biotech community and toast its future success.
The evening event, hosted by the MIT Entrepreneurship Center and the Biomedical Enterprise Program (a new collaboration between . . . [read more]
Impact of universities in Boston area illustrated by Harvard report and MIT's 1997 report
The economic impact of universities in the Boston area is measured in the billions of dollars, according to analyses released by Harvard yesterday and by MIT two years ago.
The studies, although different in nature, combine to show the direct and indirect benefit to the regional economy of these two leading universities. These figures do not include the significant role played by the many other colleges and universities in the Boston area who enroll more than 200,000 students each year.
The 1997 MIT report showed that its graduates and faculty had founded more than 1,000 . . . [read more]
MIT affiliates dominate Technology Review's TR100 list
MIT affiliates once again make up about a quarter of the TR100, a list of the world's top innovators under age 35 published in the June issue of Technology Review.
The names of five current MIT researchers and faculty members, 17 alumni and a handful of former research affiliates appeared on the list, which was formally announced at a symposium in Kresge Auditorium on May 23. This is the second time the TR100 has been compiled; MIT had 27 affiliates on the 1999 list (see MIT Tech Talk, Nov. 10, 1999).
The theme of this year's list of innovators was . . . [read more]
MIT invests in Kendall Square gateway tower at 1 Broadway
MIT, whose partnership with the City of Cambridge started the redevelopment of the Kendall Square area three decades ago with the development of Technology Square on the abandoned Lever Brothers soap factory site, announced today it has made another major investment in Kendall Square, purchasing the 17-story building at One Broadway from the Raytheon Corporation.
One Broadway, built in 1970 by the Badger Engineering Co., now a division of Raytheon, has views of the . . . [read more]
New technology is key to economic success, Vest says
President Charles Vest was the keynote speaker at a February 7 breakfast at which the Greater Boston Chamber of Commerce made public its 2001 Leading Industries Report.
The study, presented in downtown Boston to local business people and organization representatives, analyzes the competitive position of the five industries that drive greater Boston's economy and provide more than half of all employment in the region.
The report found that from 1997 to 2000 . . . [read more]
Teamwork needed for Massachusetts to lead in biotech industry, report says
The Massachusetts biotech industry, which has grown at 10 percent a year over the last five years, has an extraordinary advantage over rival states seeking biotech companies because of the strengths of its research universities, hospitals and three decades of development of the industry. But a report, "MassBiotech 2010," warned last week that an opportunity to create 150,000 new jobs in the state over the next eight years could be lost unless there is greater collaboration among state and local governments, industry and academia.
Sponsored by the Massachusetts Biotechnology Council and the Boston Consulting Group, the report said the biotech industry in Massachusetts had 30,000 jobs in 2001, one out of every eight biotech jobs in the U.S. The gain of 12,000 jobs in the Bay State represents half . . . [read more]
Fifth annual Cambridge First Day at MIT celebrates spirit of entrepreneurship
The Fifth Annual Cambridge First Day at MIT celebration was held at MIT on Tuesday, June 10, with the city of Cambridge joining MIT as the co-host for the first time.
Four Cambridge businesses received recognition awards at the event for exemplifying the spirit of entrepreneurship in the Cambridge community. Councilor Anthony D. Gallucio, chair of the City Council's Economic Development Committee, presided over the awards program. In making the presentations, he said, "The awards are given in appreciation of . . . [read more] |
